These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4797367)

  • 1. [Phenylprenazone in pediatrics. Pharmacokinetic and clinical study].
    Buffatti GA; Chierichetti S; Gamba A
    Minerva Pediatr; 1973 Sep; 25(30):1273-9. PubMed ID: 4797367
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Dotti F; Ongari R; Carazzi R; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:265-8. PubMed ID: 4553235
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antipyretic therapy with metamizole in pediatrics].
    Ottolenghi A
    Minerva Pediatr; 1971 Oct; 23(42):1781-4. PubMed ID: 5132357
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
    Scanni A; Ferrari P
    Minerva Med; 1973 Oct; 64(71):3718-24. PubMed ID: 4588363
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic and clinical effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Ghiringhelli F; Mazzi C; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:268-7. PubMed ID: 5067203
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) and oxyphenbutazone in thrombophlebitis.
    Seghezzi R; Borri P; Chierichetti S; Ferrari P
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:272-4. PubMed ID: 4553236
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.
    Lignière GC; Colombo B; Carrabba M; Ferrari P; Robotti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:253-8. PubMed ID: 4553232
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possible clinical use of benzydamine in infections].
    Spirito L
    Minerva Pediatr; 1968 May; 20(18):960-5. PubMed ID: 5740792
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in painful osteoarticular conditions.
    Pasotti C; Barbieri C; Buniva G; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:262-5. PubMed ID: 4553234
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of the antipyretic activity of 4-prenyl-1,2-diphenyl-3,5-pyrazolidindione in pediatrics].
    Vassena E; Chierichetti S
    Minerva Pediatr; 1974 Mar; 26(10):537-43. PubMed ID: 4827608
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenylprenazone in osteoarthritis.
    Cannella M; Curioni GB; Barabino P; Montanari C
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):52-5. PubMed ID: 4632506
    [No Abstract]   [Full Text] [Related]  

  • 12. Results following the use of benzydamine in the treatment of burns.
    Palmisano PA; Rossi E
    Arzneimittelforschung; 1969 Aug; 19(8):1180-3. PubMed ID: 5820283
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-activity relationships in anti-inflammatory compounds chemically related to 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Pala G; Mantegani A; Donetti A; Lumachi B; Marazzi-Uberti E; Casadio S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:174-7. PubMed ID: 5067188
    [No Abstract]   [Full Text] [Related]  

  • 14. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.
    Casadio S; Pala G; Marazzi-Uberti E; Lumachi B; Crescenzi E; Donetti A; Mantegani A; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and pharmacokinetic studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in obstetrics and gynaecology.
    Pecorari D; Ragni N; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:278-8. PubMed ID: 5067205
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-steroid anti-inflammatory agents.
    Br Med J; 1970 Aug; 3(5720):449-51. PubMed ID: 5454326
    [No Abstract]   [Full Text] [Related]  

  • 17. [New antibiotic-anti-inflammatory combination in pediatrics].
    Romoli F; Russo U
    Clin Pediatr (Bologna); 1970 Jan; 52(1):24-32. PubMed ID: 5487952
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Anti-inflammatory, analgesic and antipyretic properties.
    Bianchi C; Lumachi B; Marazzi-Uberti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:183+. PubMed ID: 5067190
    [No Abstract]   [Full Text] [Related]  

  • 19. [1st experiences in urology with a new non-steroid anti-inflammatory agent].
    Rocca Rossetti S; Oggianu F; Chierichetti S
    Minerva Urol; 1973; 25(6):276-84. PubMed ID: 4781118
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience on antibiotic therapy combined with benzydamine in acute respiratory infections in childhood].
    Caramia G; Gregorini S; Compagnoni L; Palumbo P
    Minerva Pediatr; 1985 Oct; 37(19):755-66. PubMed ID: 3911045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.